NPPA Fixes Retail Prices of 31 Drug Formulations Including Atorvastatin, Empagliflozin; Details Susmita Roy28 March 2026 8:02 PM ISTNew Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of...
Expert Panel Flags Gaps in Mascot Health's Diabetes FDC Trial, Seeks Revised Phase IV Protocol Parthika Patel27 March 2026 11:12 PM ISTNew Delhi: The Central Drugs Standard Control Organisation's (CDSCO) Subject Expert Committee (SEC) on Endocrinology and Metabolism has recommended...
CDSCO Panel Recommends Key Changes in Phase III Study of Glimepiride-Linagliptin FDC Susmita Roy22 March 2026 6:00 PM ISTNew Delhi: Considering the bioequivalence (BE) study report for Glimepiride 1 mg/2 mg plus Linagliptin 5 mg/5 mg Tablets, the Subject Expert...
SC Seeks Centre, DCGI Response on Micro Labs' Plea Against Anti-Diabetic FDC Ban Susmita Roy26 Feb 2026 10:26 PM ISTNew Delhi: The Supreme Court sought responses from the Union government and the Drug Controller General of India regarding an appeal filed by Micro...
Delhi High Court Restores Ban on Triple-Drug Diabetes Pills, Flags Safety Risks Susmita Roy16 Jan 2026 10:50 AM ISTNew Delhi: The Delhi High Court in January 2026 restored the Centre's ban on certain triple-drug fixed dose combinations (FDCs) used in the treatment...
CDSCO Alert: 64 Drug Batches Including Metformin, Paracetamol Declared Not of Standard Quality in November Susmita Roy20 Dec 2025 6:36 PM ISTNew Delhi: In a strong reminder of persistent quality concerns in India's pharmaceutical supply chain, 64 batches of drugs and medical products have...
Kerala Blocks 17 Faulty Medicines Including Rabeprazole, Ciprofloxacin After Counterfeit Seizure Parthika Patel10 Dec 2025 9:20 PM ISTThiruvananthapuram: In a major regulatory move aimed at strengthening drug safety, the Kerala government has banned the sale of 10 allopathic...
A Hidden Epidemic: Addressing Visceral Fat and Insulin Resistance in Non-Obese T2DM with Pioglitazone-Based Therapies Dr. K M Suryanarayana VSM5 Nov 2025 11:15 AM ISTMetabolically unhealthy non-obese individuals (MUNO) comprise around 20% of the normal-weight population and have a 3.14-fold higher risk of...
CDSCO Panel Rejects Pure and Cure's Empagliflozin-Based FDC, Flags Risk of UTI, Genital Mycosis Susmita Roy20 Oct 2025 5:44 PM ISTNew Delhi: Citing that there is a concern of the risk of genital mycosis and urinary tract infection (UTI) with Empagliflozin, the Subject Expert...
NPPA Fixes Retail Prices of 9 Formulations Including Dapagliflozin, Sitagliptin, Aceclofenac FDCs, Details Susmita Roy16 Sept 2025 2:00 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
Sun Pharma Fails to Secure CDSCO Nod for BE, Phase III Waiver on Sitagliptin, Glimepiride, Metformin FDC Susmita Roy7 Sept 2025 3:30 PM ISTNew Delhi: Citing the absence of supporting data for the proposed strength of the fixed-dose combination (FDC) of Sitagliptin phosphate monohydrate,...
Sun Pharma's Dapagliflozin, Glimepiride, Metformin FDC Fails to Secure CDSCO Panel Nod Over Safety, Utility Concerns Susmita Roy19 Aug 2025 3:11 PM ISTNew Delhi: Expressing doubts over the clinical utility of administering such a small dose of Glimepiride once daily, especially considering over the...
